Z-0968-2018 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-0968-2018 was initiated by Becton Dickinson & Company on Aug 29, 2017 and is designated Class II. Reason for recall: A limited portion of the lot was manufactured with less than the required amount of K2EDTA additive, an anticoagulant, which may cause erroneous results that could lead to specimen recollection and… The recall status is terminated (terminated May 16, 2019). Affected quantity: 8,494,000.

Recall details

Product Type
Devices
Report Date
Mar 21, 2018
Initiation Date
Aug 29, 2017
Termination Date
May 16, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,494,000

Product description

BD Vacutainer¿ K2 EDTA (K2E) 3.6mg Blood Collection Tube (13 x 75 mm x 2.0 mL). Catalog Number: 367841. Used for whole blood hematology determinations, immunohematology testing and blood donor screening.

Reason for recall

A limited portion of the lot was manufactured with less than the required amount of K2EDTA additive, an anticoagulant, which may cause erroneous results that could lead to specimen recollection and potential delay of treatment or misdiagnosis/mismanagement of treatment and serious complications, such as failure to detect thrombocytosis or postponing surgery.

Distribution pattern

Nationwide Distribution

Code information

Catalog No. 367841 Lot No. 6279849 UDI: (01)30382903678410

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0968-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0968-2018. Report a data issue: hello@regdatalab.com.